Literature DB >> 27491943

Practices of partnership: Negotiated safety among couples who inject drugs.

Jake Rance1, Tim Rhodes2, Suzanne Fraser3, Joanne Bryant, Carla Treloar1.   

Abstract

Despite the majority of needle-syringe sharing occurring between sexual partners, the intimate partnerships of people who inject drugs have been largely overlooked as key sites of both hepatitis C virus prevention and transmission, and risk management more generally. Drawing on interviews with 34 couples living in inner-city Australia, this article focuses on participants' accounts of 'sharing'. While health promotion discourses and conventional epidemiology have tended to interpret the practice of sharing (like the absence of condom use) in terms of 'noncompliance', we are interested in participants' socially and relationally situated 'rationalities'. Focussing on participants' lived experiences of partnership, we endeavour to make sense of risk and safety as the participants themselves do.How did these couples engage with biomedical knowledge around hepatitis C virus and incorporate it into their everyday lives and practices? Revisiting and refashioning the concept of 'negotiated safety' from its origins in gay men's HIV prevention practice, we explore participants' risk and safety practices in relation to multiple and alternative framings, including those which resist or challenge mainstream epidemiological or health promotion positions. Participant accounts revealed the extent to which negotiating safety was a complex and at times contradictory process, involving the balancing or prioritising of multifarious, often competing, risks. We argue that our positioning of participants' partnerships as the primary unit of analysis represents a novel and instructive way of thinking about not only hepatitis C virus transmission and prevention, but the complexities and contradictions of risk production and its negotiation more broadly.

Entities:  

Keywords:  hepatitis C; injecting drug use; needle–syringe sharing; negotiated safety; sexual partnerships

Mesh:

Year:  2016        PMID: 27491943     DOI: 10.1177/1363459316660859

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  11 in total

1.  Preventing transitions into injection drug use: A call for gender-responsive upstream prevention.

Authors:  Stephanie A Meyers; Laramie R Smith; Dan Werb
Journal:  Int J Drug Policy       Date:  2020-07-14

2.  The role of gender and power dynamics in injection initiation events within intimate partnerships in the US-Mexico border region.

Authors:  Stephanie A Meyers; Laramie R Smith; Maria Luisa Mittal; Steffanie A Strathdee; Richard S Garfein; Andy Guise; Dan Werb; Claudia Rafful
Journal:  Cult Health Sex       Date:  2019-10-18

3.  Examining the gender composition of drug injecting initiation events: A mixed methods investigation of three North American contexts.

Authors:  Meyers Sa; Rafful C; Mittal Ml; Smith Lr; Tirado-Muñoz J; Jain S; Sun X; Garfein Rs; Strathdee Sa; DeBeck K; Hayashi K; McNeil R; Milloy Mj; Olding M; Guise A; Werb D; Scheim Ai
Journal:  Int J Drug Policy       Date:  2020-12-11

Review 4.  Families Living with Blood-Borne Viruses: The Case for Extending the Concept of "Serodiscordance".

Authors:  Asha Persson; Christy E Newman; Myra Hamilton; Joanne Bryant; Jack Wallace; Kylie Valentine
Journal:  Interdiscip Perspect Infect Dis       Date:  2017-10-18

5.  A Systems Thinking Approach to Understanding and Demonstrating the Role of Peer-Led Programs and Leadership in the Response to HIV and Hepatitis C: Findings From the W3 Project.

Authors:  Graham Brown; Daniel Reeders; Aaron Cogle; Annie Madden; Jules Kim; Darryl O'Donnell
Journal:  Front Public Health       Date:  2018-08-31

6.  Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.

Authors:  Meghan D Morris; Erin Andrew; Judy Y Tan; Lisa Maher; Colleen Hoff; Lynae Darbes; Kimberly Page
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

7.  Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.

Authors:  Andrew Scheibe; Katherine Young; Lorraine Moses; Rudolph L Basson; Anna Versfeld; C Wendy Spearman; Mark W Sonderup; Nishi Prabdial-Sing; Jack Manamela; Adrian J Puren; Kevin Rebe; Harry Hausler
Journal:  Harm Reduct J       Date:  2019-04-11

8.  A rapid ethnographic study of risk negotiation during the COVID-19 pandemic among unstably housed people who use drugs in Rhode Island.

Authors:  Alexandra B Collins; Sarah Edwards; Ryan McNeil; Jacqueline Goldman; Benjamin D Hallowell; Rachel P Scagos; Brandon D L Marshall
Journal:  Int J Drug Policy       Date:  2022-02-17

9.  COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.

Authors:  Melissa Perri; Rose A Schmidt; Adrian Guta; Nat Kaminski; Katherine Rudzinski; Carol Strike
Journal:  Int J Drug Policy       Date:  2022-08-08

10.  HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco.

Authors:  Kimberly Page; Jennifer L Evans; Judith A Hahn; Peter Vickerman; Stephen Shiboski; Meghan D Morris
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.